SS
RGNX icon

Sunbelt Securities’s Regenxbio RGNX Stock Holding History

Sunbelt Securities’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$461 Hold
55
– – ﹤0.01% 2306
2025
Q4 		$792 Hold
55
– – ﹤0.01% 2125
2025
Q3 		$531 Buy
+55
New +$486 ﹤0.01% 2210

Other funds holding RGNX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sunbelt Securities's RGNX Position: Q1 2026 in Review

Sunbelt Securities held its Regenxbio (RGNX) position steady in Q1 2026 at 55 shares worth $461. The position accounts for ﹤0.01% of the portfolio, ranked #2306.

Sunbelt Securities first reported a position in RGNX in Q3 2025 and has held it in 3 quarters since. The position peaked at $792 in Q4 2025. 178 funds tracked by Wall St. Rank hold RGNX as of Q1 2026.

  • Sunbelt Securities held 55 shares of Regenxbio worth $461 as of Q1 2026.
  • Sunbelt Securities left its Regenxbio share count unchanged in Q1 2026.
  • Regenxbio made up ﹤0.01% of Sunbelt Securities's portfolio in Q1 2026, its #2306 holding.
  • Sunbelt Securities first reported a position in Regenxbio in Q3 2025 and has held it in 3 quarters since.
  • Sunbelt Securities's Regenxbio position peaked at $792 in Q4 2025.
  • 178 funds tracked by Wall St. Rank held Regenxbio as of Q1 2026.

Based on Sunbelt Securities's 13F filing for Q1 2026, filed 18 May 2026.